Table 4. Incorporation of oligometastasis into the MSKCC risk model.
| Model 1 | P value* | Model 2 | P value† | |
|---|---|---|---|---|
| Variables | KPS≤70 | 0.002 | KPS≤70 | 0.003 | 
| DFI <1 year | 0.237 | DFI <1 year | 0.263 | |
| Hemoglobin < LLN | 0.718 | Hemoglobin < LLN | 0.791 | |
| Corrected calcium>10mg/dL | 0.981 | Corrected calcium>10mg/dL | 0.980 | |
| LDH >1.5 × ULN | 0.057 | LDH >1.5 × ULN | 0.405 | |
| Metastatic state | 0.002 | |||
| C-index (95%CI) | 0.651 (0.571-0.732) | 0.752 (0.676-0.829) | 
Abbreviations: MSKCC=Memorial Sloan Kettering Cancer Center; KPS= Karnofsky Performance Status; DFI = disease-free interval; LDH = lactate dehydrogenase;LLN = lower limit of normal
calculated in the multivariate analysis, which includes ECOG, DFI <1 year, hemoglobin<LLN, corrected calcium >10mg/dL, and LDH >1.5 × ULN as variables.
calculated in the multivariate analysis, which includes ECOG, DFI <1 year, hemoglobin<LLN, corrected calcium >10mg/dL, LDH >1.5 × ULN, and the metastatic state as variables.